Financials data is unavailable for this security.
Inc stmt in GBPIncome statement in GBP
Year on year
Advanced Medical Solutions Group PLC grew revenues 16.42% from 83.24m to 96.91m while net income improved 28.31% from 15.69m to 20.13m.
|Net profit margin||20.78%|
|Return on assets||12.84%|
|Return on equity||14.49%|
|Return on investment||14.09%|
Cash flow in GBP
Advanced Medical Solutions Group PLC increased its cash reserves by 22.16%, or 11.33m. The company earned 16.97m from its operations for a Cash Flow Margin of 17.51%. In addition the company used 4.31m on investing activities and also paid 1.35m in financing cash flows.
|Cash flow per share||0.1079|
|Price/Cash flow per share||30.06|
|Book value per share||0.7169|
|Tangible book value per share||0.4503|
Balance sheet in GBP
|Total debt/total equity||0.00|
|Total debt/total capital||0.00|
Growth rates in GBP
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 19.57% and 27.27%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
|Div yield(5 year avg)||0.00%|
|Div growth rate (5 year)||16.17%|
|Payout ratio (TTM)||11.61%|
|EPS growth(5 years)||15.05|
|EPS (TTM) vs |
TTM 1 year ago